Owens & Minor/$OMI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Owens & Minor
Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the revenue is generated from Products & Healthcare Services segment.
Ticker
$OMI
Sector
Primary listing
NYSE
Employees
23,200
Headquarters
Website
Owens & Minor Metrics
BasicAdvanced
$348M
-
-$15.63
1.03
-
Price and volume
Market cap
$348M
Beta
1.03
52-week high
$15.54
52-week low
$4.34
Average daily volume
2.6M
Financial strength
Current ratio
0.859
Quick ratio
0.088
Long term debt to equity
-596.323
Total debt to equity
-732.617
Interest coverage (TTM)
1.99%
Profitability
EBITDA (TTM)
527.863
Gross margin (TTM)
20.89%
Net profit margin (TTM)
-11.18%
Operating margin (TTM)
2.77%
Effective tax rate (TTM)
-2.69%
Revenue per employee (TTM)
$460,000
Management effectiveness
Return on assets (TTM)
3.93%
Return on equity (TTM)
-148.42%
Valuation
Price to revenue (TTM)
0.032
Price to book
-1.24
Price to tangible book (TTM)
-0.2
Price to free cash flow (TTM)
-2.089
Free cash flow yield (TTM)
-47.87%
Free cash flow per share (TTM)
-2.159
Growth
Revenue change (TTM)
64.35%
Earnings per share change (TTM)
2,708.24%
3-year revenue growth (CAGR)
2.89%
10-year revenue growth (CAGR)
1.05%
3-year earnings per share growth (CAGR)
97.41%
10-year earnings per share growth (CAGR)
31.33%
What the Analysts think about Owens & Minor
Analyst ratings (Buy, Hold, Sell) for Owens & Minor stock.
Bulls say / Bears say
The Patient Direct segment grew revenue by 5.7% year-over-year in Q1 2025 and improved its operating margin by 173 basis points, which drove mid-teens EBITDA growth and showcased the success of the shift to higher-margin home-based care (Investing.com).
Adjusted EPS for Q1 2025 was $0.23, beating the $0.20 consensus, and adjusted EBITDA rose 4.8% to $121.9 million, reflecting disciplined cost management and improved core profitability (Investing.com).
Management reaffirmed full-year 2025 guidance, projecting revenue of $10.85 – $11.15 billion and adjusted EBITDA of $560 – $590 million, signaling confidence in achieving double-digit growth and its deleveraging targets (Investing.com).
Preliminary Q4 2024 results missed expectations, with a net loss of $311 – $288 million much larger than forecast and adjusted EBITDA at $135 – $140 million, short of the $155.5 million consensus. This led to a 25% drop in the share price and a $310 million goodwill impairment related to the Apria division (Reuters).
Operating income in the Products & Healthcare Services segment plunged to $1.2 million in Q1 2025, down from $11 million in the same period last year, as revenues declined 0.8% and margin pressure increased due to competitive pricing and rising operational costs (SEC 10-Q).
The company is facing annual tariff headwinds of $100 – $150 million in its Products & Healthcare Services segment, which could erode margins if price increases cannot be fully passed through to customers, especially amid ongoing global supply chain volatility (Alpha Spread).
Data summarised monthly by Lightyear AI. Last updated on 3 Oct 2025.
Owens & Minor Financial Performance
Revenues and expenses
Owens & Minor Earnings Performance
Company profitability
Owens & Minor News
AllArticlesVideos
Owens & Minor Announces Definitive Agreement to Divest Products & Healthcare Services Segment to Platinum Equity for $375mm in Cash and a Retained Equity Stake
Business Wire6 days ago
Apria and Byram Join New Optum Preferred DME Network
Business Wire4 weeks ago
Owens & Minor Analysts Boost Their Forecasts After Q2 Results
Benzinga2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Owens & Minor stock?
Owens & Minor (OMI) has a market cap of $348M as of October 13, 2025.
What is the P/E ratio for Owens & Minor stock?
The price to earnings (P/E) ratio for Owens & Minor (OMI) stock is 0 as of October 13, 2025.
Does Owens & Minor stock pay dividends?
No, Owens & Minor (OMI) stock does not pay dividends to its shareholders as of October 13, 2025.
When is the next Owens & Minor dividend payment date?
Owens & Minor (OMI) stock does not pay dividends to its shareholders.
What is the beta indicator for Owens & Minor?
Owens & Minor (OMI) has a beta rating of 1.03. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.